Scientific Panel

Our panel covers a wide range of disciplines and expertise. If you would like to find out more about how we can help you, please contact us.

Martyn Davies, BSc PhD FRPharmS CChem FRSC

Martyn Davies

Professor Davies has over 30 years’ experience in pharmaceutical and biological analysis and controlled drug delivery. He is Professor of Biomedical Surface Chemistry at the University of Nottingham’s School of Pharmacy. Professor Davies routinely directs the technical team at Juniper Pharma Services (f/k/a Molecular Profiles), providing expert opinion and consultancy in relation to complex litigation and R&D studies. He received his bachelor degree in Pharmacy from Brighton Polytechnic and his PhD from the London School of Pharmacy. He joined the University of Nottingham in 1985, and was head of school between 2000 and 2003. He sits on the editorial boards for Advanced Drug Delivery Reviews, the European Journal of Pharmaceutical Sciences and the Journal of Controlled Release.Supervising over 60 postgraduates, Professor Davies is the author of more than 370 peer-reviewed papers, reviews and book chapters. He is currently Vice-President for the Controlled Release Society and will be President in 2011-12.Professor Davies is a Fellow of the Royal Society for Chemistry and Royal Pharmaceutical Society of Great Britain. His research group and company have received numerous awards, including the 2003 GSK International Achievement Award. In 2007 & 2011, his company was the recipient of the Queens’ Awards for Enterprise in the category of Innovation – the highest UK business accolade.


Pharmaceuticals, biopharmaceuticals and medical devices

  • Drug delivery
  • Pharmaceutics
  • Formulation
  • Controlled release
  • Polymer science

Analytical Characterisation

  • Surface chemistry
  • Physical chemistry
  • Materials characterisation
  • Imaging
Tel: +44 (0)115 871 8877

Shen Luk, BSc PhD

Shen Luk

Dr Luk has over 20 years’ experience in academic and industrial analytical research, specialising in the analysis of complex pharmaceuticals. He is Chief Scientific Officer at Juniper Pharma Services and offers clients his expertise in the development of innovative pharmaceutical and biomedical products. He also leads our technical team, providing expert opinion and testifying in court on issues arising during patent litigation.Dr Luk’s analytical expertise includes chemical spectroscopy, surface analytical techniques, materials characterisation, chromatography, imaging and microscopy technologies. He obtained his bachelor degree in Chemistry and PhD from the University of Manchester’s Institute of Science and Technology. Before joining Juniper Pharma Services in 2000, he spent 10 years at Courtaulds Corporate Research Laboratories providing analytical support.On numerous occasions Dr Luk has presented at conferences on the topic of analysis of pharmaceutical formulations. As part of Juniper Pharma Services, Dr. Luk has won recognition for the company’s work, most recently in 2011 when we received the Queen’s Award for Enterprise in the category of Continuous Innovation – the highest UK business accolade.


Pharmaceutical analysis

  • Materials characterisation
  • Vibrational spectroscopy
  • Microscopy and imaging technologies
  • Polymorphism
  • Pharmaceutical analysis
  • Polymer analysis
  • Surface analysis
Tel: +44 (0)115 871 8877

Lisbeth Illum, MPharm PhD DSc

Lisbeth Illum

Professor Illum has 35 years’ industrial and academic experience in drug delivery. She was the founder and, for 12 years, the Managing Director of DanBioSyst UK Ltd (now part of West Pharmaceuticals), and the Managing Director of Phaeton Research Ltd. She has also consulted for several multinational pharmaceutical companies. Awarded an MPharm, PhD and DSc from the Royal Danish School of Pharmacy in 1972, 1978 and 1988 respectively, her research expertise covers novel drug delivery systems for difficult drugs – such as polar small molecular weight compounds, and peptides and proteins. She has studied novel delivery approaches for drugs using transmucosal routes (nasal, oral and vaginal). Professor Illum has lectured throughout the world. She has published more than 300 scientific papers and co-edited four books including Peptide Drug Delivery Systems. Professor Illum has filed nearly 50 patents on novel drug delivery systems and either is or used to be on the editorial boards of seven scientific journals, including the Journal of Pharmaceutical Science and Pharmaceutical Research. Among several scientific awards, Professor Illum was awarded title of Docent by the Royal Danish School of Pharmacy, and in 2007 picked up the Eurand Career Achievement Award. She has been elected a Fellow of the AAPS and was the President of the Controlled Release Society in 2008.


Pharmaceutical and biopharmaceutical drug delivery

  • Peptide and protein delivery
  • Controlled release formulations
  • Nasal delivery
  • Transmucosal delivery
  • Pulmonary delivery
  • Depot formulations
Tel: +44 (0)115 871 8877

Bob Davis, BPharm PhD DSc FRSC CChem FRPharmS

Bob Davis

Professor Stanley (Bob) Davis has over 40 years’ academic and industrial experience in drug delivery. As well as being the co-founder of two companies – Danbiosyst (UK) (now part of West Pharmaceuticals) and Pharmaceutical Profiles – he was formerly the Lord Trent Professor in Pharmacy at the University of Nottingham (1975-2005). Professor Davis has consulted for numerous companies globally on drug delivery, as well as acting as an expert in patent litigation matters. He obtained his bachelor degree in Pharmacy and PhD from the University of London. In 1982, he was awarded a Doctor of Science degree (higher doctorate) and has supervised over 50 PhD students. He is the author of over 700 peer reviewed papers, the co-editor of seven books, holds seven patents and sits on editorial boards for various high-impact journals. Professor Davis has also served on numerous committees and panels, including those of the British and European Pharmacopoeias, the United Kingdom Medicines Commission and the Science and Engineering Council. He is a Fellow of the Royal Society of Chemistry, Royal Pharmaceutical Society of Great Britain and the American Academy of Pharmaceutical Sciences. The recipient of numerous awards, Professor Davis most notably received the Høst Madsen award for lifetime achievement in pharmaceutical sciences from the International Federation of Pharmacy; the federation’s highest scientific award.


Pharmaceutical and biopharmaceutical drug delivery

  • Drug delivery
  • Controlled release formulations
  • Pharmaceutics
  • Colloid Science
  • Physical pharmacy
  • GI tract absorption
  • In vitro – in-vivo correlation
Tel: +44 (0)115 871 8877

Gerald Pattenden, FRS


Professor Gerald Pattenden has over 40 years’ experience in organic chemistry and is Professor of Organic Chemistry at the University of Nottingham. He is also a Fellow of the Royal Society, the UK national science academy comprising the most eminent scientists. He has consulted widely for the pharmaceutical, chemical, agrochemical and food industries and has also acted as an expert consultant in patent litigation matters. Professor Pattenden received his bachelor degree in Chemistry from Brunel University and his PhD from Queen Mary College, University of London. He was awarded a Doctor of Science degree (higher doctorate) from the University of London in 1990. He researches in the broad area of design and development of novel organic synthesis methods, addressing the total synthesis of natural products of biological and medicinal importance. Publishing over 450 peer reviewed papers, he was, from 1988 to 1996, the Head of the Department of Chemistry at the University of Nottingham and, from 1997 to 2003, Pro Vice-Chancellor (Vice President) for Research. Professor Pattenden has served on numerous committees and panels, including as President of the Perkin Division of the Royal Society of Chemistry (1995-1997). He has also been the Editor and a member of editorial advisor boards of several organic chemistry journals worldwide, including J. Chem. Soc. Perkin Transactions 1. His contributions have been recognised by numerous awards including the 1997 Royal Society of Chemistry Award for Natural Product Chemistry and the Hugo Müller Lectureship of the Royal Society of Chemistry in 2000.


Organic chemistry

  • Organic synthesis
  • Medicinal chemistry
  • Chemical form and structure
  • Chiral chemistry
Tel: +44 (0)115 871 8877

Philip Williams, BPharm PhD FRPharmS


Professor Williams has over 20 years’ experience in pharmaceutical and biopharmaceutical analysis. He is Professor of Biophysics and head of division of Biophysics and surface analysis within the faculty of science at the University of Nottingham. Professor Williams has acted as an expert consultant in patent litigation matters in the USA and Canada. His pharmaceutical analysis expertise includes the application of imaging and confocal microscopy technologies to study complex systems. He obtained both his bachelor degree in Pharmacy and PhD from the University of Nottingham and has authored over 150 peer-reviewed publications, reviews and book chapters in the field of molecular simulation and biomaterial characterisation. In 2000, he was one of only 13 academics in the UK to be awarded the five-year EPSRC Research Fellowship. He is currently an EPSRC panel member. Professor Williams has received a number of awards including the GSK International Achievement award, given jointly to the LBSA and Molecular Profiles (now Juniper Pharma Services) in 2003. Notably in 2004, in recognition of “distinction in science related to pharmacy”, he became a Fellow of the Royal Pharmaceutical Society of Great Britain. Aged just 37 at the time, this made him one of the youngest pharmacists ever to be made a Fellow. In 2007/2011 he was recognised as part of both Molecular Profiles and the University’s Pharmacy School with the honour of two Queen’s Awards for Enterprise in the category of Innovation – the highest UK business accolade.


Pharmaceutical and biopharmaceutical characterisation

  • Pharmaceutical formulations
  • Physical pharmaceutical chemistry
  • Biopharmaceutical delivery
  • Biological structure
  • Molecular simulation
Tel: +44 (0)115 871 8877

Kevin Shakesheff, FRPharmS FSB UK registered pharmacist


Kevin Shakesheff is Director of the UK Regenerative Medicine Platform Hub for Acellular Technologies. His independent scientific career began at the Massachusetts Institute of Technology under a NATO fellowship following a PhD and his qualification as a registered pharmacist. He returned to the UK as an EPSRC Advanced Fellow and became Professor of Tissue Engineering and Drug delivery in 2001 at the University of Nottingham. In 2013 he became a Royal Society Wolfson Merit Award Holder. He was a Sub-Panel Member for the Research Excellence Framework (REF) for 2014. In 2011 he was made a Fellow of the Royal Pharmaceutical Society and in 2013 a Fellow of the Society of Biologists. In 2014 he was selected as one of the 10 most inspirational scientists in the UK by the Engineering and Physical Sciences Research Council (RISE Leader Award). Kevin’s research involves the use of materials to control drug release and cell behaviour in 3D.


Polymer chemistry and processing

  • Surfactants
  • Biodegradable and resorbable polymers
  • Manufacturing methods
  • Use of supercritical fluids and thermoresponsive materials
  • Polymore blends and copolymers
  • Nano and microparticles

Drug delivery

  • Sustained and delayed release
  • Minimally invasive delivery
  • Phase changing materials for injection


  • Formulation of proteins
  • Controlled release
  • Targeting and intracellular delivery

Regenerative medicine

  • Cell therapies and administration
  • Tissue engineering scaffolds
  • Growth factor and drug delivery to promote tissue repair
  • Stem cell technologies

Materials characterisation

  • Surface chemistry using XPS
  • Surface topography by AFM
  • Mechanical testing and rheology
Tel: +44 (0)115 871 8877

Morgan Alexander, BSc PhD FRSC


Morgan Alexander is Professor of Biomedical, a Royal Society-Wolfson Research Merit Award holder and a Wellcome Trust Senior Investigator. He received his Bachelor of Science in Materials in 1988 and his PhD from the same department at The University of Sheffield in 1992. His work involves developing materials for application in human healthcare and characterising relationships between surface structure and biological properties. Understanding these relationships is critical to the development of biomaterials and it is the theme running through his group’s work across a variety of areas spanning controlling bacterial adhesion to stem cell response for application in medical devices and cell manufacture.


Drug delivery & Characterisation

  • Biomaterials
  • Medical devices
  • Surface characterisation
Tel: +44 (0)115 871 8877

Mike Claybourn, BSc PhD

MIKE (2)

After a short academic career in the field of physics of advanced materials, Mike moved into industry where he has gained more than 25 years experience in R&D, including periods at ICI and most recently at AstraZeneca.
As a Principal Scientist at AstraZeneca Mike managed an Innovation team as well as providing problem solving capabilities throughout the business. During this period, he published in areas including process development, process analytical technology (PAT), stability prediction, materials for drug delivery, materials sterilisation, product security, drug mode of activity and technology innovation. Since 2013, Mike has supported pharmaceutical product development and manufacturing, including process understanding, problem solving and developing new IPs for a variety of clients. In addition, Mike assists the business development in technology with a portfolio of clients covering major suppliers to the Pharma industry as well as start-up companies.


  • Pharmaceutical Development
  • Pharmaceutical Manufacture
  • Analytical Development
  • Process Analytical Technologies
Tel: +44 (0)115 871 8877